nach oben

Die Radiologie

Erschienen in:

28.04.2017 | Digitale Volumentomographie | Leitthema

Prostataarterienembolisation (PAE)

Technik und Ergebnisse

verfasst von: PD Dr. A. Kovács

Erschienen in: Die Radiologie | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Klinisches/methodisches Problem

Bei der Behandlung des benignen Prostatasyndroms (BPS) haben sich medikamentöse und operative Verfahren etabliert.

Radiologische Standardverfahren

Die Prostataarterienembolisation (PAE), die innovative, endovaskuläre Therapie des BPS hat das Potenzial, die Lücke zwischen diesen Verfahren zu schließen.

Leistungsfähigkeit

Die PAE gilt als sicher und nebenwirkungsarm. Die Effektivität der PAE ist bei mittelgroßen und großen Drüsen sowie intravesikalen Protrusionen belegt.

Bewertung

Der komplexe Wirkmechanismus der PAE hat das Potential, sowohl Beschwerden zu lindern, wie auch die Progression der Erkrankung zu hemmen.

Empfehlung für die Praxis

Daten über die langfristige therapeutische Effektivität fehlen derzeit.

Hong SJ, Rayford W, Valiquette L, Emberton M (2005) The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management. BJU Int 95(1):15–19CrossRefPubMed

Nair-Shalliker V, Yap S, Nunez C, Egger S, Rodger J, Patel MI, O’Connell DL, Sitas F, Armstrong BK, Smith DP (2017) Adult body size, sexual history and adolescent sexual development, may predict risk of developing prostate cancer: results from the New South Wales Lifestyle and Evaluation of Risk Study (CLEAR). Int J Cancer 140(3):565–574. doi:10.1002/ijc.30471 CrossRefPubMed

Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2012) Ständige Kommission Leitlinien. AWMF-Regelwerk „Leitlinien“. 1. Auflage. S2e Leitlinie – Therapie des Benignen Prostatasyndroms (BPS). http://www.awmf.org/leitlinien/awmf-regelwerk.html. Zugegriffen: 28 Feb 2017

Sun F, Crisóstomo V, Báez-Díaz C, Sánchez FM (2016) Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): part 1, pathological background and clinical implications. Cardiovasc Intervent Radiol 39(1):1–7CrossRefPubMed

Sun F, Crisóstomo V, Báez-Díaz C, Sánchez FM (2016) Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): part 2, insights into the technical rationale. Cardiovasc Intervent Radiol 39(2):161–169CrossRefPubMed

Pereira AJ, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, Martins Pisco J (2012) Patient selection and counseling before prostatic arterial embolization. Tech Vasc Interv Radiol 15(4):270–275CrossRef

McWilliams JP, Kuo MD, Rose SC, Bagla S, Caplin DM, Cohen EI, Faintuch S, Spies JB, Saad WE, Nikolic B, Society of Interventional Radiology (2014) Society of Interventional Radiology position statement: prostate artery embolization for treatment of benign disease of the prostate. J Vasc Interv Radiol 25(9):1349–1351CrossRefPubMed

Franiel T, Quentin M, Mueller-Lisse UG, Schimmoeller L, Asbach P, Rödel S, Willinek W, Hueper K, Beyersdorff D, Röthke M (2017) MRI of the prostate: recommendations on patient preparation and scanning protocol. Rofo 189(1):21–28PubMed

Park HY, Lee JY, Park SY, Lee SW, Kim YT, Choi HY, Moon HS (2012) Efficacy of alpha blocker treatment according to the degree of intravesical prostatic protrusion detected by transrectal ultrasonography in patients with benign prostatic hyperplasia. Korean J Urol 53(2):92–97CrossRefPubMedPubMedCentral

10.

Park YJ, Bae KH, Jin BS, Jung HJ, Park JS (2012) Is increased prostatic urethral angle related to lower urinary tract symptoms in males with benign prostatic hyperplasia/lower urinary tract symptoms? Korean J Urol 53(6):410–413CrossRefPubMedPubMedCentral

11.

Kim BH, Kim KH, Ko YH, Song PH, Kim TH, Kim BS (2016) The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: a multicenter study. Prostate Int 4(1):30–35CrossRefPubMedPubMedCentral

12.

Bilhim T, Pisco JM, Furtado A, Casal D, Pais D, Pinheiro LC, O’Neill JE (2011) Prostatic arterial supply: demonstration by multirow detector angio CT and catheter angiography. Eur Radiol 21(5):1119–1126CrossRefPubMed

13.

Aminsharifi A, Salehi A, Noorafshan A, Aminsharifi A, Alnajar K (2016) Effect of preoperative finasteride on the volume or length density of prostate vessels, intraoperative, postoperative blood loss during and after monopolar transurethral resection of prostate: a dose escalation randomized clinical trial using stereolog methods. Urol J 13(1):2562–2568PubMed

14.

Börgermann C, Kaufmann A, Sperling H, Stöhrer M, Rübben H (2010) The treatment of stress incontinence in men: part 2 of a series of articles on incontinence. Dtsch Arztebl Int 107(27):484–491PubMedPubMedCentral

15.

Bilhim T, Pisco JM, Rio Tinto H, Fernandes L, Pinheiro LC, Furtado A, Casal D, Duarte M, Pereira J, Oliveira AG, O’Neill JE (2012) Prostatic arterial supply: anatomic and imaging findings relevant for selective arterial embolization. J Vasc Interv Radiol 23(11):1403–1415CrossRefPubMed

16.

Zhang G, Wang M, Duan F, Yuan K, Li K, Yan J, Chang Z, Wang Y (2015) Radiological findings of prostatic arterial anatomy for prostatic arterial embolization: preliminary study in 55 Chinese patients with benign prostatic hyperplasia. PLOS ONE 10(7):e0132678CrossRefPubMedPubMedCentral

17.

Garcia-Monaco R, Garategui L, Kizilevsky N, Peralta O, Rodriguez P, Palacios-Jaraquemada J (2014) Human cadaveric specimen study of the prostatic arterial anatomy: implications for arterial embolization. J Vasc Interv Radiol 25(2):315–322CrossRefPubMed

18.

de Assis AM, Moreira AM, de Paula Rodrigues VC, Harward SH, Antunes AA, Srougi M, Carnevale FC (2015) Pelvic arterial anatomy relevant to prostatic artery embolisation and proposal for angiographic classification. Cardiovasc Intervent Radiol 38(4):855–861CrossRefPubMed

19.

Bagla S, Sterling KM (2014) Pitfalls of cone beam computed tomography in prostate artery embolization. Cardiovasc Intervent Radiol 37(6):1430–1435CrossRefPubMed

20.

Carnevale FC, Moreira AM, Antunes AA (2014) The „PErFecTED technique“: proximal embolization first, then embolize distal for benign prostatic hyperplasia. Cardiovasc Intervent Radiol 37(6):1602–1605CrossRefPubMed

21.

Carnevale FC, Antunes AA, da Motta Leal Filho JM, de Oliveira Cerri LM, Baroni RH, Marcelino AS, Freire GC, Moreira AM, Srougi M, Cerri GG (2010) Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol 33(2):355–361CrossRefPubMed

22.

Amouyal G, Thiounn N, Pellerin O, Yen-Ting L, Del Giudice C, Dean C, Pereira H, Chatellier G, Sapoval M (2016) Clinical results after prostatic artery embolization using the PErFecTED technique: a single-center study. Cardiovasc Intervent Radiol 39(3):367–375CrossRefPubMed

23.

Frenk NE, Baroni RH, Carnevale FC, Gonçalves OM, Antunes AA, Srougi M, Cerri GG (2014) MRI findings after prostatic artery embolization for treatment of benign hyperplasia. AJR Am J Roentgenol 203(4):813–821CrossRefPubMed

24.

Schreuder SM, Scholtens AE, Reekers JA, Bipat S (2014) The role of prostatic arterial embolization in patients with benign prostatic hyperplasia: a systematic review. Cardiovasc Intervent Radiol 37(5):1198–1219CrossRefPubMed

25.

Uflacker A, Haskal ZJ, Bilhim T, Patrie J, Huber T, Pisco JM (2016) Meta-analysis of prostatic artery embolization for benign prostatic hyperplasia. J Vasc Interv Radiol 27(11):1686–1697CrossRefPubMed

26.

Pisco JM, Rio Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes L, Pereira J, Oliveira AG (2013) Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol 23(9):2561–2572CrossRefPubMed

27.

Li Q, Duan F, Wang MQ, Zhang GD, Yuan K (2015) Prostatic arterial embolization with small sized particles for the treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia: preliminary results. Chin Med J (Engl) 128(15):2072–2077CrossRef

28.

Wang M, Guo L, Duan F, Yuan K, Zhang G, Li K, Yan J, Wang Y, Kang H (2016) Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. BJU Int 117(1):155–164CrossRefPubMed

29.

30.

Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, Duarte M, Oliveira AG (2016) Medium- and long-term outcome of prostate artery embolization for patients with benign prostatic hyperplasia: results in 630 patients. J Vasc Interv Radiol 27(8):1115–1122CrossRefPubMed

31.

Lin YT, Amouyal G, Thiounn N, Pellerin O, Pereira H, Del Giudice C, Déan C, Sapoval M (2016) Intra-vesical Prostatic Protrusion (IPP) can be reduced by prostatic artery embolization. Cardiovasc Intervent Radiol 39(5):690–695CrossRefPubMed

32.

Ahmed AF (2016) Sonographic parameters predicting the outcome of patients with lower urinary tract symptoms/benign prostatic hyperplasia treated with alpha1-adrenoreceptor antagonist. Urology 88:143–148CrossRefPubMed

33.

Gao YA, Huang Y, Zhang R, Yang YD, Zhang Q, Hou M, Wang Y (2014) Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate-a prospective, randomized, and controlled clinical trial. Radiology 270(3):920–928CrossRefPubMed

34.

Cao Y, Wang Y, Guo L, Yang X, Chen T, Niu H (2016) A randomized, open-label, comparative study of efficacy and safety of Tolterodine combined with Tamsulosin or Doxazosin in patients with benign prostatic hyperplasia. Med Sci Monit 22:1895–1902CrossRefPubMedPubMedCentral

35.

Bagla S, Smirniotopoulos JB, Orlando JC, van Breda A, Vadlamudi V (2015) Comparative analysis of prostate volume as a predictor of outcome in prostate artery embolization. J Vasc Interv Radiol 26(12):1832–1838CrossRefPubMed

36.

Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M (2016) Transurethral Resection of the Prostate (TURP) versus original and PErFecTED Prostate Artery Embolization (PAE) due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol 39(1):44–52CrossRefPubMed

37.

Yu SC, Cho CC, Hung EH, Chiu PK, Yee CH, Ng CF (2017) Prostate artery embolization for complete urinary outflow obstruction due to benign prostatic hypertrophy. Cardiovasc Intervent Radiol 40(1):33–40CrossRefPubMed

38.

Carnevale FC, da Motta-Leal-Filho JM, Antunes AA, Baroni RH, Marcelino AS, Cerri LM, Yoshinaga EM, Cerri GG, Srougi M (2013) Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia. J Vasc Interv Radiol 24(4):535–542CrossRefPubMed

39.

Bilhim T, Pisco J, Rio Tinto H, Fernandes L, Campos Pinheiro L, Duarte M, Pereira JA, Oliveira AG, O’Neill J (2013) Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement. Cardiovasc Intervent Radiol 36(2):403–411CrossRefPubMed

40.

Bilhim T, Pisco J, Campos Pinheiro L, Rio Tinto H, Fernandes L, Pereira JA, Duarte M, Oliveira AG (2013) Does polyvinyl alcohol particle size change the outcome of prostatic arterial embolization for benign prostatic hyperplasia? Results from a single-center randomized prospective study. J Vasc Interv Radiol 24(11):1595–1602CrossRefPubMed

41.

Bilhim T, Pisco J, Pereira JA, Costa NV, Fernandes L, Campos Pinheiro L, Duarte M, Oliveira AG (2016) Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology 281(1):289–300CrossRefPubMed

42.

Wang XY, Zong HT, Zhang Y (2016) Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis. Clin Interv Aging 11:1609–1622CrossRefPubMedPubMedCentral

43.

Feng S, Tian Y, Liu W, Li Z, Deng T, Li H, Wang K (2017) Prostatic arterial embolization treating moderate-to-severe lower urinary tract symptoms related to benign prostate hyperplasia: a meta-analysis. Cardiovasc Intervent Radiol 40(1):22–32CrossRefPubMed

44.

Moreira AM, Marques CF, Antunes AA, Nahas CS, Nahas SC, de Gregorio Ariza MA, Carnevale FC (2013) Transient ischemic rectitis as a potential complication after prostatic artery embolization: case report and review of the literature. Cardiovasc Intervent Radiol 36(6):1690–1694CrossRefPubMed

Titel: Prostataarterienembolisation (PAE)
Technik und Ergebnisse
verfasst von: PD Dr. A. Kovács
Publikationsdatum: 28.04.2017
Verlag: Springer Medizin
Schlagwörter: Digitale Volumentomographie
Benigne Prostatahyperplasie
Benigne Prostatahyperplasie
TURP
Erschienen in: Die Radiologie / Ausgabe 8/2017
Print ISSN: 2731-7048
Elektronische ISSN: 2731-7056
DOI: https://doi.org/10.1007/s00117-017-0248-5

Passend zum Thema

Phytotherapie bei CPPS

Pollstimol®: Leitliniengerechte Prostatitis-Therapie

In 90 % der Prostatitis-Fälle handelt es sich um eine chronische abakterielle Prostatitis (chronic pelvic pain syndrome, CPPS) mit anhaltender Entzündungsreaktion und Schwellung der Prostata. Als leitliniengerechte Behandlungsoption mit guter Evidenz hat sich das Phytotherapeutikum Pollstimol® etabliert.

Springer Medizin

Zusammenfassung

Klinisches/methodisches Problem

Radiologische Standardverfahren

Leistungsfähigkeit

Bewertung

Empfehlung für die Praxis

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2017

Mitteilungen des Berufsverbandes der Deutschen Radiologen

Die Vorsteherdrüse – was möchte der Urologe vom Radiologen wissen?

Prostata

Irreversible Elektroporation (IRE)

Interventionelle Therapie der benignen Prostatahyperplasie

Ultraschall der Prostata

Passend zum Thema

Pollstimol®: Leitliniengerechte Prostatitis-Therapie